Ecs Botanics Holdings Ltd (AU:ECS) has released an update.
ECS Botanics Holdings Ltd, a leader in medicinal cannabis, reports a successful Q4 with a 12% revenue increase to $4.5 million and a record 6.8-tonne harvest, fueling competition against cheaper imports. The company is well-capitalized, with $3.2 million in cash and a further $2 million NAB facility undrawn, positioning it for growth through B2C sales and expansion of production capabilities. Despite a slight downturn from the previous year, ECS retains a strong customer base and is making strategic investments in its brand and international partnerships.
For further insights into AU:ECS stock, check out TipRanks’ Stock Analysis page.
